ANTISENSE THERAPEUTICS
Antisense Therapeutics is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
ANTISENSE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2000-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.antisense.com.au
Total Employee:
1+
Status:
Active
Contact:
+61 (3) 9827 8999
Total Funding:
7.61 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Maps Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Google Maps API Microsoft Azure DNS CPanel Google Maps For Work
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Employees Featured
Stock Details
Investors List
Circadian Ventures
Circadian Ventures investment in Post-IPO Equity - Antisense Therapeutics
PowerOne Capital Markets Limited
PowerOne Capital Markets Limited investment in Post-IPO Equity - Antisense Therapeutics
Official Site Inspections
http://www.antisense.com.au
- Host name: s1.hostservers.com.au
- IP address: 103.100.38.86
- Location: Bengaluru India
- Latitude: 12.9721
- Longitude: 77.5933
- Timezone: Asia/Kolkata
- Postal: 560066
More informations about "Antisense Therapeutics"
Antisense Therapeutics Ltd. Management Team | Org Chart
The Company is developing ATL1102, an antisense inhibitor of the CD49d receptor, for Duchenne muscular dystrophy (DMD) patients and recently reported highly promising Phase II trial …See details»
Antisense Therapeutics Company Profile | Management and
About Antisense Therapeutics Limited (ASX: ANP) is an Australian publicly listed biopharmaceutical company, developing and commercialising antisense pharmaceuticals for …See details»
Antisense Therapeutics CEO announces retirement For personal …
Www.antisense.com.au 1300 932 037 +1 646-653-7035 For personal use only _____ ANTISENSE THERAPEUTICS LIMITED - ABN 41 095 060 745 About Antisense Therapeutics …See details»
Antisense Share Purchase Plan Raises $3.26 Million
Aug 21, 2023 LEVEL 1, 14 WALLACE AVENUE, TOORAK VIC 3142 AUSTRALIA TEL . +61 (3) 9827 8999 FAX +61 3 9859 7701 WEB WWW.ANTISENSE.COM.AU ANTISENSE …See details»
Antisense Therapeutics - Craft
Jan 3, 2024 Antisense Therapeutics is a biopharmaceutical drug discovery and development company. It creates and commercializes antisense drug candidates (ATL1103, ATL1102) for …See details»
ANP News, Analysis, Announcements & Results | Antisense …
Feb 8, 2012 Antisense Therapeutics (ANP) The junior biotech and drug discovery company rallied to a year high after saying it had entered into an exclusive agreement with Teva …See details»
Antisense Therapeutics - PharmiWeb.com
Antisense Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The …See details»
Antisense Therapeutics Ltd (ASX:ANP) Share Price - Market Index
Antisense Therapeutics Limited (ANP) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize …See details»
ANTISENSE THERAPEUTICS LIMITED (ANP) - InvestoGain
The securities of Antisense Therapeutics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ANP, pending the release of an announcement …See details»
Antisense Therapeutics (ASX:ANP) appoints Chief Commercial Officer
Nov 3, 2022 Percheron Therapeutics Limited (ASX:PER) News (Video) - 03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief …See details»
Antisense Therapeutics Ltd. Overview - SignalHire
Antisense Therapeutics Ltd. is a public company that has been in the industry for 34 years. The company currently specializes in the Pharmaceuticals area. The position of the CEO is …See details»
Antisense Therapeutics Ltd. - BioCentury Company Profiles - BCIQ
Antisense Therapeutics Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Antisense Therapeutics - Funding, Financials, Valuation & Investors
Antisense Therapeutics is registered under the ticker ASX:ANP . Stock Symbol ASX:ANP ; IPO Date Dec 21, 2001; Stock chart by . Investors. Edit Investors Section. Number of Investors 2. …See details»
Antisense Therapeutics (ASX:ANP) discusses ... - Finance News …
03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attracting …See details»
Antisense Therapeutics - Edison Group
Antisense Therapeutics is an Australian biotechnology company developing antisense oligonucleotide (ASO) therapies for the treatment of rare diseases. Its lead asset, ATL1102, is …See details»
Antisense Therapeutics announces the appointment of new CEO …
May 9, 2023 Antisense Therapeutics (ASX:ANP) has announced the appointment of Dr James Garner as its new chief executive officer and managing director. Dr Garner will assume the …See details»
Antisense (ASX: ANP) Discuss Upcoming AGM & New Appointment
Nov 4, 2022 Antisense Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare …See details»
ASX Announcement Antisense Therapeutics Limited - Listed …
Jan 3, 2020 6 WALLACE AVENUE, TOORAK VIC 3142 AUSTRALIA TEL . +61 (3) 9827 8999 FAX +61 (3) 9827 1166 WEB WWW.ANTISENSE.COM.AU ANTISENSE THERAPEUTICS …See details»
Systematic analysis of genetic and phenotypic characteristics …
14 hours ago Background Neurodevelopmental disorders (NDDs) are a challenging group of disorders to treat, but promising therapeutic interventions in the form of antisense …See details»